ALKEM Laboratories has announced changes concerning two senior management personnel. Mr. Ravinder Chaklam has superannuated from the Company, ceasing his senior management role effective March 24, 2026. Separately, Mr. Mukesh Tiwari has been appointed to a role within a wholly owned subsidiary, resulting in his cessation as a senior management position within the main Company effective October 1, 2025. The company noted the delay in disclosure was due to an unintentional oversight.
Senior Management Transitions Announced
ALKEM Laboratories has formally disclosed key movements within its senior management structure as per regulatory requirements. These changes affect two senior leaders and are effective on different dates.
Cessation of Mr. Ravinder Chaklam
The company confirms that Mr. Ravinder Chaklam has ceased to hold a senior management position. This change is due to his superannuation from the Company, with the cessation effective from March 24, 2026.
Cessation of Mr. Mukesh Tiwari
Furthermore, Mr. Mukesh Tiwari has also ceased to hold a senior management position within the Company. This change is concurrent with his appointment to a role within the company’s wholly owned subsidiary, effective from October 1, 2025.
Disclosure Note
The organization acknowledged that the full disclosure details regarding these movements were provided subsequent to the actual effective dates. The company stated that this delay was unintentional and resulted from an oversight on the part of ALKEM Laboratories.
Source: BSE
